Abiopharma

Arcus Biosciences - Arcus Chief Operations Officer Departs for Role as CEO

FORM 3-INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES-Davidi Ishay

HyBryte™ Treatment Results to be Presented at US Cutaneous Lymphoma Consortium Annual Workshop 2026

Leading Independent Proxy Advisory Firm Glass Lewis Endorses Aptose Plan of Arrangement

Cabaletta Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

ASP Isotopes Completes Well Drilling Required for Phase 1 of Renergen Helium Project Four Months Ahead of Schedule

Anavex Life Sciences Presents New Data from its AD-004 Phase IIb/III Trial at AD/PD 2026 Conference Demonstrating Consistent Correlation Between the Treatment Effect of Oral Blarcamesine and Preservation of Brain Volume in Early Alzheimer’s Disease

Xilio Therapeutics Announces Pipeline and Business Updates and Fourth Quarter and Full Year 2025 Financial Results

Ford and Major League Baseball Unite to Celebrate America’s Pastime and the People Who Power It

TWO Determines Unsolicited Proposal from CrossCountry Mortgage is a “Company Superior Proposal”